Parameter | 5-Bromo-4,6-dichloropyrimidine | Analogous Compounds |
---|---|---|
CAS Number | 68797-61-5 | 36082-50-5 (structural isomer) |
Molecular Formula | C4HBrCl2N2 | C4HCl2N2Br |
Molecular Weight | 227.87 g/mol | 227.87 g/mol |
Purity Grade | ≥98% (HPLC) | 95-97% (standard) |
Thermal Stability | Stable below 230°C | Decomposes at 200°C |
This heterocyclic compound serves as a crucial building block in:
Handling Protocols:
Reactivity Profile:
Case 1: Anticancer Drug Development
A Shanghai-based biotech company utilized this compound as a core structure in tyrosine kinase inhibitor research, achieving 73% yield in lead compound optimization.
Case 2: OLED Material Synthesis
Jiangsu materials laboratory reported enhanced electron mobility (12.3 cm²/V·s) in semiconductor layers using brominated pyrimidine derivatives.
Client A: Contract Research Organization
Achieved 40% reduction in synthesis steps for antipsychotic API using our compound as a key intermediate (Batch size: 150kg, Purity: 99.2%).
Client B: Academic Research Institute
Published Nature Chemistry paper on novel C-H activation methods using this reagent, citing 89% reaction efficiency.
For technical specifications, bulk pricing, or custom synthesis requirements:
Our chemical engineering team provides:
This is William, CEO of fousi chemical Chemical Co., Ltd.
Welcome to visit our factory . As the top chemical manufacturer, we have been striving for product quality, innovation , R&D, and customer service for the past 7 years. In the next 10 years or even longer, we are committed to becoming the most reliable chemical supplier in the world , creating a well-known international brand trusted by customers, with the spirit of “one meter wide, ten thousand meters deep”, we continue to focus on product research and development, continue to focus on customer service, continue to improve the supply chain service system, to create a professional chemical supply service team, to achieve win-win long-term cooperation. Please feel free to contact us if you have any questions.